Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Lan-Qing, Yao"'
Autor:
Wan Yee Lau, Timothy M Pawlik, Wei-Yue Chen, Zhi-Peng Liu, Qing-Yu Kong, Li-Yang Sun, Yong-Yi Zeng, Ying-Jian Liang, Ya-Hao Zhou, Ting-Hao Chen, Zi-Xiang Chen, Ming-Da Wang, Lan-Qing Yao, Jian-Song Ji
Publikováno v:
eGastroenterology, Vol 1, Iss 1 (2023)
Background The role of adjuvant transarterial chemoembolisation (TACE) to reduce postoperative recurrence varies widely among patients undergoing hepatectomy with curative intent for hepatocellular carcinoma (HCC). Personalised predictive tool to sel
Externí odkaz:
https://doaj.org/article/8714c570cba64371b65a1feddb796670
Publikováno v:
Liver Research, Vol 6, Iss 3, Pp 132-138 (2022)
Hepatocellular carcinoma (HCC), a typical inflammatory-related cancer, mainly occurs in patients with chronic liver diseases. Moreover, the liver is an immunologically privileged apparatus with multiple immunosuppressive cell groups. The long process
Externí odkaz:
https://doaj.org/article/1076298e3692403c9af3c19f8b2660fa
Autor:
Si-Yu Liu, Chao Li, Li-Yang Sun, Ming-Cheng Guan, Li-Hui Gu, Dong-Xu Yin, Lan-Qing Yao, Lei Liang, Ming-Da Wang, Hao Xing, Hong Zhu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Xiang-Min Tong, Tian Yang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe GALAD and ASAP scores are two well-recognized algorithms to estimate the risk of hepatocellular carcinoma (HCC) based on gender, age, alpha-fetoprotein (AFP), protein induced by vitamin K absence or Antagonist-II (PIVKA-II) and AFP-L3 (
Externí odkaz:
https://doaj.org/article/590af4d18bcd43bca900c1d143a34ddb
Autor:
Xin-Fei Xu, Han Wu, Ju-Dong Li, Lan-Qing Yao, Bin Huang, Yong-Kang Diao, Ting-Hao Chen, Wei-Min Gu, Zhong Chen, Jie Li, Yao-Ming Zhang, Hong Wang, Ying-Jian Liang, Ya-Hao Zhou, Chao Li, Ming-Da Wang, Cheng-Wu Zhang, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
Publikováno v:
Hepatobiliary Surgery and Nutrition. 12:314-327
Autor:
Han Wu, Wei-Min Gu, Timothy M. Pawlik, Wen-Tao Yan, Xin-Fei Xu, Hai-Bo Qiu, Wan Yee Lau, Chao Li, Jian-Hong Zhong, Ting-Hao Chen, Ya-Hao Zhou, Feng Shen, Lan-Qing Yao, Ming-Da Wang, Tian Yang, Hong Wang
Publikováno v:
Hepatobiliary Surgery and Nutrition. 12:155-168
Autor:
Xin-Fei Xu, Yong-Kang Diao, Yong-Yi Zeng, Chao Li, Feng-Wei Li, Li-Yang Sun, Han Wu, Kong-Ying Lin, Lan-Qing Yao, Ming-Da Wang, Cheng-Wu Zhang, Wan Yee Lau, Feng Shen, Tian Yang
Publikováno v:
International Journal of Surgery. 109:841-849
Publikováno v:
Journal of Oncology. 2023:1-8
Hepatocellular carcinoma (HCC) is a highly lethal and heterogeneous malignancy with multiple genetic alternations and complex signaling pathways. The complexity and multifactorial nature of HCC pose a tremendous challenge regarding its diagnosis and
Autor:
Shun-Chao Yang, Lei Liang, Ming-Da Wang, Xian-Ming Wang, Li-Hui Gu, Kong-Ying Lin, Ya-Hao Zhou, Ting-Hao Chen, Wei-Min Gu, Jie Li, Hong Wang, Zhong Chen, Chao Li, Lan-Qing Yao, Yong-Kang Diao, Li-Yang Sun, Cheng-Wu Zhang, Yong-Yi Zeng, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang
Publikováno v:
HPB. 25:81-90
The Eastern Staging System, which was specially developed for patients undergoing surgical resection for hepatocellular carcinoma (HCC), has been proposed for more than ten years. To prospectively validate the predictive accuracy of the Eastern stagi
Autor:
Zi-Han Feng, Ming-Da Wang, Zhong Chen, Li-Yang Sun, Xiao Xu, Qing-Yu Kong, Zi-Xiang Chen, Yong-Yi Zeng, Ying-Jian Liang, Zhi-Yu Chen, Hong Wang, Ya-Hao Zhou, Ting-Hao Chen, Lan-Qing Yao, Chao Li, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
Publikováno v:
Surgery. 172:1147-1155
Data on recurrence are important to inform surveillance and improve long-term surgical outcomes for patients with hepatocellular carcinoma. We sought to identify risk factors and long-term prognosis among patients who experienced beyond-Milan recurre
Autor:
Ming-Da, Wang, Shi-Chuan, Tang, Chao, Li, Li-Yang, Sun, Xiao, Xu, Ying-Jian, Liang, Fu-Bao, Liu, Wei-Min, Gu, Xian-Ming, Wang, Ya-Hao, Zhou, Wan Yee, Lau, Cheng-Wu, Zhang, Lan-Qing, Yao, Yong-Kang, Diao, Li-Hui, Gu, Feng, Shen, Yong-Yi, Zeng, Tian, Yang
Publikováno v:
Annals of Surgical Oncology. 30:346-358
Although hepatitis B virus (HBV) infection remains the main cause of hepatocellular carcinoma (HCC) worldwide, metabolic syndrome, with its increase in prevalence, has become an important and significant risk factor for HCC. This study was designed t